Botulinum Toxin-A Injection in the Treatment of Spasticity in a Infantile-Onset Neurodegeneration With Brain Iron Accumulation: A Case Report

Botulinum Toxin-A Injection in the Treatment of Spasticity in a Infantile-Onset Neurodegeneration With Brain Iron Accumulation: A Case Report

Pantothenate kinase-associated neurodegeneration (PKAN) is a neurodegenerative disorder characterized by iron accumulation in the globus pallidus (GP) of the brain (neurodegeneration with brain iron accumulation [NBIA]), which is characterized by dystonia and spasticity resulting in postural difficu...

Full description

Bibliographic Details
Main Authors:	Hwan Kwon Do, Geun Yeol Jo, Jun Koo Kwon, Woo Jin Kim
Format:	Article
Language:	English
Published:	Korean Academy of Rehabilitation Medicine 2018-04-01
Series:	Annals of Rehabilitation Medicine
Subjects:	Neurodegeneration with brain iron accumulation (NBIA) Pantothenate kinase-associated neurodegeneration (PKAN)
Online Access:	http://www.e-arm.org/upload/pdf/arm-42-363.pdf

Similar Items

Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration
by: Paolo Santambrogio, et al.
Published: (2020-05-01)

Neurodegeneration with brain iron accumulation: A case report
by: Daniel Nassif, et al.

Ironing out the pathophysiology of neurodegeneration with brain iron accumulation (NBIA) : clinical investigations and disease modelling yield novel evidence of systemic dysfunction and provide a robust and accurate disease model of NBIA
by: Minkley, Michael
Published: (2018)

All that glitters is not gold: When motor and vocal tics in a child do not match Tourette syndrome: A case report
by: Raquel Quimas Molina da Costa, et al.

Neurodegeneration with brain iron accumulation for stem-cell therapy: Anesthetic management
by: Ruchi A Jain, et al.
Published: (2018-01-01)

Neurodegeneration with Brain Iron Accumulation Disorders: Valuable Models Aimed at Understanding the Pathogenesis of Iron Deposition
by: Sonia Levi, et al.
Published: (2019-02-01)

Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments
by: Saeed Razmeh, et al.
Published: (2018-04-01)

A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
by: Mohammad Rohani, et al.
Published: (2018-02-01)

Brain, blood, and iron: Perspectives on the roles of erythrocytes and iron in neurodegeneration
by: Rainer Prohaska, et al.
Published: (2012-06-01)

Precision medicine in pantothenate kinase-associated neurodegeneration
by: Mónica Alvarez-Cordoba, et al.
Published: (2019-01-01)

Novel PANK2 mutation identified in patient with pantothenate kinase-associated neurodegeneration
by: Svetel Marina, et al.
Published: (2020-01-01)

Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders
by: Vassilena Iankova, et al.
Published: (2021-04-01)

Brain MRI Pattern Recognition in Neurodegeneration With Brain Iron Accumulation
by: Jae-Hyeok Lee, et al.
Published: (2020-09-01)

An international registry for neurodegeneration with brain iron accumulation
by: Kalman Bernadette, et al.
Published: (2012-09-01)

A new in vivo model of pantothenate kinase-associated neurodegeneration reveals a surprising role for transcriptional regulation in pathogenesis.
by: Varun ePandey, et al.
Published: (2013-09-01)

Atypical pantothenate kinase-associated neurodegeneration with variable phenotypes in an Egyptian family
by: Ali S. Shalash, et al.
Published: (2021-07-01)

Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms.
by: Sonia eLevi, et al.
Published: (2014-05-01)

Pantothenate kinase-associated neurodegeneration (Hallerworden–Spatze disease): clinical aspects, diagnosis, treatment (literature review and own data)
by: Yu. H. Antypkin, et al.
Published: (2021-10-01)

Coenzyme a Biochemistry: From Neurodevelopment to Neurodegeneration
by: Luca Mignani, et al.
Published: (2021-08-01)

Autosomal dominant mitochondrial membrane protein‐associated neurodegeneration (MPAN)
by: Allison Gregory, et al.
Published: (2019-07-01)

Erratum: A new in vivo model of pantothenate kinase-associated neurodegeneration reveals a surprising role for transcriptional regulation in pathogenesis
by: Frontiers in Neuroscience Editorial Office
Published: (2013-10-01)

Novel Compound Heterozygous Mutations in the Pantothenate Kinase 2 Gene in a Korean Patient with Atypical Pantothenate Kinase Associated Neurodegeneration
by: Sung-Hyouk Kim, et al.
Published: (2009-05-01)

An overview of Neurodegeneration with brain iron accumulation (NBIA) syndromes and the disease status in Iranian population: review article
by: Reza Hajati, et al.
Published: (2020-04-01)

Two unusual cases of PLA2G6-associated neurodegeneration from India
by: Shilpa D Kulkarni, et al.
Published: (2016-01-01)

Advances in inherited and clinical research of pantothenate kinase⁃associated neurodegeneration
by: Xiao⁃yuan LI, et al.
Published: (2012-06-01)

Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
by: Mónica Álvarez-Córdoba, et al.
Published: (2021-05-01)

4′‐Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN
by: Suh Young Jeong, et al.
Published: (2019-12-01)

Intellectual Disability, Falls and Gait Disturbances: A Misdiagnosis
by: Noel Lorenzo Villalba, et al.
Published: (2020-02-01)

A Novel Deletion Mutation of Exon 2 of the C19orf12 Gene in an Omani Family with Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN)
by: Nabil Al Macki, et al.
Published: (2017-01-01)

A novel homozygous variation in the PANK2 gene in two Persian siblings with atypical pantothenate kinase associated neurodegeneration
by: Amir Hasan Habibi, et al.
Published: (2019-03-01)

Neuronal Ablation of CoA Synthase Causes Motor Deficits, Iron Dyshomeostasis, and Mitochondrial Dysfunctions in a CoPAN Mouse Model
by: Ivano Di Meo, et al.
Published: (2020-12-01)

Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports
by: Hassan Dastsooz, et al.
Published: (2017-08-01)

Treatment of infantile neuroaxonal dystrophy with RT001: A di‐deuterated ethyl ester of linoleic acid: Report of two cases
by: Darius Adams, et al.
Published: (2020-07-01)

Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation
by: Maura Poli, et al.
Published: (2010-08-01)

Rare neurogenetic diseases with paramagnetic material accumulation in the brain: A case series study
by: Murat Yilmaz, et al.
Published: (2021-01-01)

Clinical Heterogeneity of Atypical Pantothenate Kinase-Associated Neurodegeneration in Koreans
by: Jae-Hyeok Lee, et al.
Published: (2016-01-01)

Neurodegeneration with Brain Iron Accumulation: Diagnosis and Management
by: Penelope Hogarth
Published: (2015-01-01)

BRAIN IRON ACCUMULATION: DON’T FORGET ACERULOPLASMINEMIA
by: Paola Feraco
Published: (2020-07-01)

Knock-down of pantothenate kinase 2 severely affects the development of the nervous and vascular system in zebrafish, providing new insights into PKAN disease
by: Daniela Zizioli, et al.
Published: (2016-01-01)

Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
by: Randall D. Marshall, et al.
Published: (2019-07-01)